Drug Trial Radar · NCT07843264
PPI Dosing Per CYP2C19 Genotype
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Nov 1, 2026
Primary completion
Dec 31, 2027
Study completion Apr 1, 2028
Sponsor
- Lead sponsor
- University of FloridaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is being done to determine if the dosing of proton pump inhibitor (PPI) medication based on CYP2C19 genotype-derived phenotype leads to improved healing of erosive esophagitis compared to conventional PPI medication dosing.
Conditions
- Gastroesophageal Reflux Disease With Esophagitis
Interventions
CYP2C19 based dosing Proton Pump InhibitorsDrug
Pantoprazole dosing based on CYP2C19 phenotypes
Conventional proton pump inhibitor doseDrug
conventional PPI dose of Pantoprazole 40 mg once or twice daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Improvement of Los Angeles (LA) classification of Erosive Esphagitis (EE) gradeTime frame: 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
UF Health
Jacksonville, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.